A. Neil Howell
Corporate Officer/Principal at University of Texas Medical Branch
Profile
A.
Neil Howell joined MIGENIX, Inc. in August 2004 as Vice President of Research.
Previously, he had served as Vice President of Research at MitoKor in 2000.
He was a tenured Professor in the Department of Radiation Oncology at the University of Texas Medical Branch at Galveston, where he serves as an Adjunct Professor.
Dr. Howell held several professorial positions at the University of Texas Medical Branch in Galveston and at Harvard Medical School.
He was a Member of the Grant Review Committees at the National Institutes of Health and the National Science Foundation.
Dr. Howell received a BA from the University of Kansas and a PhD in Molecular Biology from the University of Wisconsin.
A. Neil Howell active positions
Companies | Position | Start |
---|---|---|
University of Texas Medical Branch | Corporate Officer/Principal | - |
Former positions of A. Neil Howell
Companies | Position | End |
---|---|---|
MIGENIX, Inc.
MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada. | Chief Tech/Sci/R&D Officer | - |
MitoKor, Inc.
MitoKor, Inc. BiotechnologyHealth Technology MitoKor, Inc. provided discovery and diagnostic development of mitochondrial medicine. It was a biotechnology company focused on the research and development of drugs for the treatment of major diseases and conditions associated with mitochondrial dysfunction. The company was headquartered in San Diego, CA | Chief Tech/Sci/R&D Officer | - |
Training of A. Neil Howell
University of Kansas | Undergraduate Degree |
University of Wisconsin | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
MitoKor, Inc.
MitoKor, Inc. BiotechnologyHealth Technology MitoKor, Inc. provided discovery and diagnostic development of mitochondrial medicine. It was a biotechnology company focused on the research and development of drugs for the treatment of major diseases and conditions associated with mitochondrial dysfunction. The company was headquartered in San Diego, CA | Health Technology |
MIGENIX, Inc.
MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada. | Health Technology |
- Stock Market
- Insiders
- A. Neil Howell